287 related articles for article (PubMed ID: 7958693)
1. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis.
Sokol RJ; Twedt D; McKim JM; Devereaux MW; Karrer FM; Kam I; von Steigman G; Narkewicz MR; Bacon BR; Britton RS
Gastroenterology; 1994 Dec; 107(6):1788-98. PubMed ID: 7958693
[TBL] [Abstract][Full Text] [Related]
2. A comparison of copper-loading disease in Bedlington terriers and Wilson's disease in humans.
Su LC; Ravanshad S; Owen CA; McCall JT; Zollman PE; Hardy RM
Am J Physiol; 1982 Sep; 243(3):G226-30. PubMed ID: 7114265
[TBL] [Abstract][Full Text] [Related]
3. Inherited copper toxicosis in Bedlington terriers: Wilson's disease (hepatolenticular degeneration).
Owen CA; Ludwig J
Am J Pathol; 1982 Mar; 106(3):432-4. PubMed ID: 7065120
[No Abstract] [Full Text] [Related]
4. Copper toxicosis in non-COMMD1 Bedlington terriers is associated with metal transport gene ABCA12.
Haywood S; Boursnell M; Loughran MJ; Trafford J; Isherwood D; Liu X; Olohan L; Carter SD
J Trace Elem Med Biol; 2016 May; 35():83-9. PubMed ID: 27049130
[TBL] [Abstract][Full Text] [Related]
5. Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease.
Mansouri A; Gaou I; Fromenty B; Berson A; Lettéron P; Degott C; Erlinger S; Pessayre D
Gastroenterology; 1997 Aug; 113(2):599-605. PubMed ID: 9247482
[TBL] [Abstract][Full Text] [Related]
6. Oxidant injury to hepatic mitochondrial lipids in rats with dietary copper overload. Modification by vitamin E deficiency.
Sokol RJ; Devereaux M; Mierau GW; Hambidge KM; Shikes RH
Gastroenterology; 1990 Oct; 99(4):1061-71. PubMed ID: 2394327
[TBL] [Abstract][Full Text] [Related]
7. Hemostasis in the copper-laden Bedlington terrier: a possible model of Wilson's disease.
Owen CA; Bowie EJ; McCall JT; Zollman PE
Haemostasis; 1980; 9(3):160-6. PubMed ID: 7372201
[TBL] [Abstract][Full Text] [Related]
8. Fragmentation of mitochondrial cardiolipin by copper ions in the Atp7b-/- mouse model of Wilson's disease.
Yurkova IL; Arnhold J; Fitzl G; Huster D
Chem Phys Lipids; 2011 Jul; 164(5):393-400. PubMed ID: 21645498
[TBL] [Abstract][Full Text] [Related]
9. Copper and hepatic function.
Owen CA
Ciba Found Symp; 1980; 79():267-82. PubMed ID: 6907088
[TBL] [Abstract][Full Text] [Related]
10. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
Chowrimootoo GF; Ahmed HA; Seymour CA
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
[TBL] [Abstract][Full Text] [Related]
11. Copper inhibition of the thiobarbituric acid reaction in Bedlington terriers.
Hultgren BD; Menken BZ; Csallany AS
Am J Vet Res; 1986 Apr; 47(4):818-9. PubMed ID: 3963583
[TBL] [Abstract][Full Text] [Related]
12. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
[TBL] [Abstract][Full Text] [Related]
13. Pathological mitochondrial copper overload in livers of Wilson's disease patients and related animal models.
Zischka H; Lichtmannegger J
Ann N Y Acad Sci; 2014 May; 1315():6-15. PubMed ID: 24517326
[TBL] [Abstract][Full Text] [Related]
14. Metal-induced hepatotoxicity.
Britton RS
Semin Liver Dis; 1996 Feb; 16(1):3-12. PubMed ID: 8723319
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatocellular localization of copper in Wilson's disease.
Yano M; Sakamoto N; Takikawa T; Hayashi H
Nagoya J Med Sci; 1993 Mar; 55(1-4):131-7. PubMed ID: 8247102
[TBL] [Abstract][Full Text] [Related]
16. Animal models of copper-associated liver disease.
Fuentealba IC; Aburto EM
Comp Hepatol; 2003 Apr; 2(1):5. PubMed ID: 12769823
[TBL] [Abstract][Full Text] [Related]
17. Compliance in Wilson's disease and in copper toxicosis of Bedlington terriers.
Hoogenraad TU; Rothuizen J
Lancet; 1986 Jul; 2(8499):170. PubMed ID: 2873435
[No Abstract] [Full Text] [Related]
18. Structural and metabolic changes in Atp7b-/- mouse liver and potential for new interventions in Wilson's disease.
Huster D
Ann N Y Acad Sci; 2014 May; 1315():37-44. PubMed ID: 24697742
[TBL] [Abstract][Full Text] [Related]
19. The level of serum lipids, vitamin E and low density lipoprotein oxidation in Wilson's disease patients.
Rodo M; Czonkowska A; Pulawska M; Swiderska M; Tarnacka B; Wehr H
Eur J Neurol; 2000 Sep; 7(5):491-4. PubMed ID: 11054132
[TBL] [Abstract][Full Text] [Related]
20. Uneven hepatic copper distribution in Wilson's disease.
Faa G; Nurchi V; Demelia L; Ambu R; Parodo G; Congiu T; Sciot R; Van Eyken P; Silvagni R; Crisponi G
J Hepatol; 1995 Mar; 22(3):303-8. PubMed ID: 7608481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
